Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Rangering i aksjer #40615
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Aksjekurs
$0.13607016
Sist synkronisert: 2024-09-10
Markedsverdi
$112.29K
Endring (1 dag)
22.46%
Endring (1 år)
0.00%
Land
GB
Handel BiVictriX Therapeutics Plc (BVX)

Kategori

Pris BVX pris med markedsverdi på B
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
BVX
$0.13607016
Markedsverdi av BiVictriX Therapeutics Plc(BVX)
Markedsverdi: $112.29K
Per August 2026 har BiVictriX Therapeutics Plc en markedsverdi på $112.29K. Dette gjør BiVictriX Therapeutics Plc til det 40615th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for BiVictriX Therapeutics Plc fra 2021 til 2026
BVX sammenlignet med topp 5 mest populære stocks
Pris på BVX Eiendel B Markedsverdi for B Resultater
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$6,623,006 $112.29K
$5.466T +4,867,346,307.19%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$5,401,565 $112.29K
$4.458T +3,969,690,853.63%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$5,059,044 $112.29K
$4.175T +3,717,967,519.13%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$4,445,328 $112.29K
$3.669T +3,266,938,182.15%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$3,457,554 $112.29K
$2.853T +2,541,008,022.90%